US Antimony files Form 144 to sell common stock
US Antimony (UAMY) submitted a Form 144 reporting proposed sales of common stock.
Rhea-AI Filing Summary
US Antimony (UAMY) submitted a Form 144 reporting proposed sales of common stock. The filing lists two restricted common share entries of 66,667 shares dated 03/03/2025 and 05/15/2024 and reports 30,000 shares sold during the past three months on 03/25/2026.
The notice names Merrill (address shown) as the broker and indicates the securities trade on the NYSE. The filing is a routine notification of proposed or recent dispositions of restricted common stock.
Positive
- None.
Negative
- None.
Insights
Routine Form 144 notice of proposed and recent restricted share sales.
The filing lists two restricted common stock entries of 66,667 shares dated 03/03/2025 and 05/15/2024, and discloses 30,000 shares sold on 03/25/2026. It names Merrill as the broker and shows NYSE as the market.
These notices are administrative disclosures required for planned or completed dispositions by insiders or affiliates; cash‑flow treatment and holder identities beyond the broker are not detailed in the excerpt. Subsequent public filings would show further activity if holders execute additional sales.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does US Antimony's (UAMY) Form 144 report list?
Are the listed securities restricted or unrestricted in the UAMY Form 144?
Which broker and exchange are named in the UAMY Form 144 filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.